Literature DB >> 32559523

The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention.

Ching-Hui Sia1, Aloysius Sheng-Ting Leow2, Benjamin Yong-Qiang Tan3, Christopher Junyan Low4, Rajinderdeep Kaur5, Tiong-Cheng Yeo6, Mark Yan-Yee Chan6, Edgar Lik-Wui Tay6, Leonard Leong-Litt Yeo7, Eng-Soo Yap8, Joshua Ping-Yun Loh6.   

Abstract

BACKGROUND: Left ventricular thrombosis (LVT) is a potentially devastating complication in post-acute myocardial infarction (AMI) patients. Previous studies have demonstrated that inflammation may contribute to thrombus formation, but its role on thrombus resolution is uncertain. The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are easily accessible haematological markers of inflammation.
OBJECTIVES: We aimed to identify differences between post-AMI LVT patients with and without LVT resolution, and to evaluate the utility of NLR and PLR in predicting LVT resolution.
METHODS: We included 289 consecutive post-AMI patients with LVT. Acute LVT was diagnosed based on echocardiogram. Patients were stratified based on LVT resolution. Logistic regression was performed to evaluate for independent predictors of thrombus resolution.
RESULTS: Compared to post-AMI patients with eventual LVT resolution, those with unresolved LVT had more co-morbidities such as hypertension (p = 0.003) and ischaemic heart disease (p < 0.001), fewer underwent percutaneous coronary intervention (PCI) (p < 0.001) or were treated with triple therapy (p < 0.001). NLR (p = 0.064) and PLR (p = 0.028) were higher in unresolved LVT patients. In non-PCI patients, NLR (OR 0.818, 95% CI 0.674-0.994, p = 0.043) and PLR (OR 0.989, 95% CI 0.979-0.999, p = 0.026) were independent predictors of thrombus resolution after adjustment for age and anticoagulation use.
CONCLUSIONS: Post-AMI patients not receiving PCI may have a greater inflammatory response and a higher NLR and PLR, which is associated with less LVT resolution despite anticoagulation. Further studies are required to study this association.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Left ventricular thrombus; Neutrophil-lymphocyte ratio; Percutaneous coronary intervention; Platelet-lymphocyte ratio; Thrombus resolution

Mesh:

Year:  2020        PMID: 32559523     DOI: 10.1016/j.thromres.2020.06.003

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Are Associated with Recurrent Ischemic Stroke in Patients with Embolic Stroke of Undetermined Source.

Authors:  Tony Y W Li; Ching-Hui Sia; Bernard P L Chan; Jamie S Y Ho; Aloysius S Leow; Mark Y Chan; Pipin Kojodjojo; Mary Joyce Galupo; Hock-Luen Teoh; Vijay K Sharma; Raymond C S Seet; Leonard L L Yeo; Benjamin Yong-Qiang Tan
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

2.  Risk factors for in-hospital systemic thromboembolism in myocardial infarction patients with left-ventricular thrombus: A multicenter retrospective study.

Authors:  Wei Zhou; Shun-Yi Shi; Fei Ye; Yuan Ji; Jun Huang; Song Yang; Lin Yang; Shenglan Huang
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

3.  Novel predictor of the occurrence of DKA in T1DM patients without infection: A combination of neutrophil/lymphocyte ratio and white blood cells.

Authors:  Yiping Cheng; Wenhao Yu; Yuping Zhou; Tao Zhang; Haiyan Chi; Chao Xu
Journal:  Open Life Sci       Date:  2021-12-31       Impact factor: 0.938

4.  Predictive value of inflammation-based Glasgow prognostic score, platelet-lymphocyte ratio, and global registry of acute coronary events score for major cardiovascular and cerebrovascular events during hospitalization in patients with acute myocardial infarction.

Authors:  Xiaoqun Xu; Long Cai; Tielong Chen; Shibiao Ding; Fengwei Zhang; Beibei Gao; Houyong Zhu; Jinyu Huang
Journal:  Aging (Albany NY)       Date:  2021-07-16       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.